Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
Bertaut A, Truntzer C, Madkouri R, Kaderbhai CG, Derangère V, Vincent J, Chauffert B, Aubriot-Lorton MH, Farah W, Mourier KL, Boidot R, Ghiringhelli F.
Bertaut A, et al.
Oncotarget. 2016 Oct 25;7(43):70948-70958. doi: 10.18632/oncotarget.10898.
Oncotarget. 2016.
PMID: 27487142
Free PMC article.